Generation Bio Co Stock Technical Analysis

GBIO Stock  USD 5.34  0.40  6.97%   
As of the 8th of February, Generation Bio retains the Market Risk Adjusted Performance of 0.305, risk adjusted performance of 0.0226, and Downside Deviation of 2.33. Generation Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Generation Bio Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Generation, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GenerationGeneration Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Generation Bio Analyst Consensus

Target PriceConsensus# of Analysts
5.25Buy7Odds
Generation Bio Co current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Generation analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Generation stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Generation Bio, talking to its executives and customers, or listening to Generation conference calls.
Generation Analyst Advice Details
Will Biotechnology sector continue expanding? Could Generation diversify its offerings? Factors like these will boost the valuation of Generation Bio. Market participants price Generation higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Generation Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(9.37)
Revenue Per Share
2.277
Quarterly Revenue Growth
(0.79)
Return On Assets
(0.27)
Return On Equity
(0.81)
Generation Bio's market price often diverges from its book value, the accounting figure shown on Generation's balance sheet. Smart investors calculate Generation Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Generation Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Generation Bio 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Generation Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Generation Bio.
0.00
11/10/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/08/2026
0.00
If you would invest  0.00  in Generation Bio on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Generation Bio Co or generate 0.0% return on investment in Generation Bio over 90 days. Generation Bio is related to or competes with Verrica Pharmaceuticals, Jasper Therapeutics, NextCure, Evaxion Biotech, Q32 Bio, Boundless Bio, and SAB Biotherapeutics. Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases More

Generation Bio Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Generation Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Generation Bio Co upside and downside potential and time the market with a certain degree of confidence.

Generation Bio Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Generation Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Generation Bio's standard deviation. In reality, there are many statistical measures that can use Generation Bio historical prices to predict the future Generation Bio's volatility.
Hype
Prediction
LowEstimatedHigh
3.215.347.47
Details
Intrinsic
Valuation
LowRealHigh
2.754.887.01
Details
7 Analysts
Consensus
LowTargetHigh
4.785.255.83
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.61-0.61-0.61
Details

Generation Bio February 8, 2026 Technical Indicators

Generation Bio Backtested Returns

Generation Bio holds Efficiency (Sharpe) Ratio of close to zero, which attests that the entity had a close to zero % return per unit of risk over the last 3 months. Generation Bio exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Generation Bio's Downside Deviation of 2.33, market risk adjusted performance of 0.305, and Risk Adjusted Performance of 0.0226 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Generation Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Generation Bio is expected to be smaller as well. At this point, Generation Bio has a negative expected return of -0.0163%. Please make sure to check out Generation Bio's sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Generation Bio performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.07  

Virtually no predictability

Generation Bio Co has virtually no predictability. Overlapping area represents the amount of predictability between Generation Bio time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Generation Bio price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Generation Bio price fluctuation can be explain by its past prices.
Correlation Coefficient0.07
Spearman Rank Test-0.17
Residual Average0.0
Price Variance0.01
Generation Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Generation Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Generation Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Generation Bio Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Generation Bio volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Generation Bio Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Generation Bio Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Generation Bio Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Generation Bio price pattern first instead of the macroeconomic environment surrounding Generation Bio. By analyzing Generation Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Generation Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Generation Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2024 2025 2026 (projected)
Interest Debt Per Share14.0412.649.38
Revenue Per Share2.992.692.82

Generation Bio February 8, 2026 Technical Indicators

Most technical analysis of Generation help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Generation from various momentum indicators to cycle indicators. When you analyze Generation charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Generation Bio February 8, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Generation stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Will Biotechnology sector continue expanding? Could Generation diversify its offerings? Factors like these will boost the valuation of Generation Bio. Market participants price Generation higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Generation Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(9.37)
Revenue Per Share
2.277
Quarterly Revenue Growth
(0.79)
Return On Assets
(0.27)
Return On Equity
(0.81)
Generation Bio's market price often diverges from its book value, the accounting figure shown on Generation's balance sheet. Smart investors calculate Generation Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Generation Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.